Jingzi Zhangbao
12 Wulumuqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Clinical characteristics of IgG4-related hypertrophic pachymeningitis with and without serum ANCA positivity.
Journal: Journal of neuroimmunology
Published: May 08, 2026
Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparison With Rituximab.
Journal: Annals of clinical and translational neurology
Published: November 27, 2025
Outcomes and predictors of relapse and severe pneumonia in Chinese patients with AQP4-IgG-positive neuromyelitis optica spectrum disorder receiving inebilizumab: a prospective cohort study.
Journal: Frontiers in immunology
Published: October 04, 2025
CXCL9 associates with experimental neuromyelitis optica spectrum disorder following adoptive transfer of Tfh and Th17 cells.
Journal: Frontiers in immunology
Published: September 12, 2025
Dysregulated Tfh/B cells and their interactions in neuromyelitis optica spectrum disorder.
Journal: Frontiers in immunology
Published: September 12, 2025
Retinal nerve fiber layer thinning in multiple sclerosis: clinical implications, cognitive associations, and effects of disease-modifying therapies.
Journal: Journal of neurology
Published: August 31, 2025
Glial fibrillary acidic protein autoimmunity in reversible splenial lesion syndrome: diagnostic and therapeutic implications.
Journal: Frontiers in neurology
Published: June 19, 2025
Eculizumab for the acute attack of neuromyelitis optica spectrum disorder.
Journal: Frontiers in immunology
Published: June 11, 2025
External validation of the MOG-AR score for predicting post-attack relapse risk in a chinese cohort with MOGAD.
Journal: Multiple sclerosis and related disorders
Published: June 09, 2025
Neuronal intranuclear inclusion disease with recurrent encephalitis.
Journal: BMC neurology
Published: May 19, 2025
Last Updated: 09/26/2026